🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Factbox-U.S. IPO activity plunges as Ukraine war triggers volatility

Published 08/10/2022, 05:15 AM
Updated 08/10/2022, 11:02 AM
© Reuters. FILE PHOTO: A trader works on the trading floor at the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S., August 3, 2022. REUTERS/Andrew Kelly
HG
-

(Reuters) - Market volatility triggered by Russia's invasion of Ukraine and soaring global interest rates has forced investors to pull back from backing initial public offerings, resulting in a dramatic decline in stock market listings in the United States.

According to data from Refinitiv, 2022 is on track to be the worst year for U.S. listings since 2009, with IPOs having raised roughly $5 billion in the first seven months this year - a 96% decline from the same period in 2021, according to Refinitiv.

Nevertheless, some companies have braved a frigid IPO market and gone public on U.S. stock exchanges this year.

Following is a list of the 10 largest IPOs since March:

Company Capital Stock Background

raised performance

since

listing

Bausch + $712 mln -16% in New Eyewear co, was taken

Lomb Corp York private by private

equity firm Warburg

-17% in Pincus in 2007, and

Toronto later by Canada-based

Valeant

Pharmaceuticals for

$8.57 bln in 2013.

Excelerate $384 mln -21% Founded by energy

Energy Inc tycoon George

Kaiserhe, the LNG

provider's IPO was

the first major U.S.

IPO since Russia

invaded Ukraine.

ProFrac $288 mln -1% Provides hydraulic

Holding fracturing services,

Corp a process that breaks

up underground

bedrock to free up

oil or gas reserves.

Hillevax $200 mln -32% Boston,

Inc Massachusetts-based

co is currently

developing a vaccine

for immunization

against

gastroenteritis.

Ivanhoe $169 mln -24% Mining tycoon Robert

Electric Friedland-led company

Inc focuses on metals for

electrification such

as copper, gold,

silver, nickel.

PepGen Inc $108 mln -28% Clinical-stage

biotech is developing

treatments for

neurological

diseases.

AN2 $79 mln -40% Menlo Park-based co

Therapeutic provides therapies

s Inc for treatment of

chronic diseases.

Hanover ~$27 mln -7% Offers financial

Bancorp Inc services, loans,

mortgages and card

services.

Intelligent $25 mln -84% Hong Kong-based

Living company designs lock

Application sets and smart

Group Inc security systems.

Nano Labs $20 mln -7% China-based chipmaker

Ltd designs products that

can be used for

cryptocurrency

© Reuters. FILE PHOTO: A trader works on the trading floor at the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S., August 3, 2022. REUTERS/Andrew Kelly

mining.

Source: Dealogic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.